In gliomas, HERV-K (HML-2) expression has been detected in specific tumor samples and cell lines through reverse transcriptase-qPCR; however, the extent and depth of HERV expression in gliomas has not been established to date17,18. Here, CLEC10A is linked to central nervous system cancer.